GSK

Lobbying Organisation GSK

Date published 21 May, 2025

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2025 to 30 Apr, 2025

Specific Details Immunisation policy

Intended results To establish a national immunisation programme for Shingles

Name of person primarily responsible for lobbying on this activity Eimear Caslin

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Letter (1)

Letter requesting a meeting with CMO

Informal communication (2-5)

Informal interactions regarding shingles NIP at conferences- Croke Park and Kilkenny

Email (2-5)

Email to CMO responding to letter she sent to GSK and email communication to Senators providing information on Shingles vaccination

Phone call (2-5)

Phone call with DPOs giving them information on Shingles vaccine and discussing implementation of a potential national immunisation programme

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Mary Horgan Chief Medical Officer (Department of Health)

Evanne Ní Chuilinn Senator (Seanad)

Seán Kyne Senator (Seanad)

Garret Ahearn Senator (Seanad)

Dr Colm Henry Chief Clinical Officer (Health Service Executive)